On June 3, 2024 Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, reported that management will participate in the following investor conferences in June (Press release, Bicycle Therapeutics, JUN 3, 2024, View Source [SID1234643995]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Global Healthcare Conference on Wednesday, June 5, 2024; fireside chat at 8:30 a.m. ET
Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024; fireside chat at 1:20 p.m. ET
TD Cowen 2nd Annual Radiopharmaceutical Innovation Summit on Monday, June 17, 2024; fireside chat at 3:00 p.m. ET
Live webcasts of the fireside chats will be accessible in the Investor section of the Company’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available following the fireside chat dates.